\-\ Texto\\:\\ \ \(0\)\
\-\ therapy\\ is\\ primarily\\ medical\\ although\\ some\\ believe\\ medically\\ refractory\\ seizures\\ may\\ be\\ cured\\ with\\ resection\\.\ \(0\)\
\-\ well\\ defined\\ rounded\\ supracellar\\ solid\\ mass\\ that\\ appears\\ to\\ arise\\ from\\ or\\ near\\ the\\ floor\\ of\\ the\\ third\\ ventricle\\.\\ \\ this\\ mass\\ is\\ non\\-enhancing\\ and\\ isointense\\ to\\ gray\\ matter\\ on\\ t1wi\\ and\\ slightly\\ hyperintense\\ to\\ gray\\ matter\\ on\\ t2wi\\.\ \(0\)\
\-\ hypothalamic\\ hamartoma\ \(0\)\
\-\ grade\\ ii\\ astrocytoma\ \(0\)\
\-\ sarcoidosis\\ and\\ other\\ granulomatous\\ diseases\\ i\\.e\\.\\ tb\ \(0\)\
\-\ arachnoid\\ cyst\ \(53\)\
\-\ teratoma\\ or\\ other\\ germ\\ cell\\ tumors\ \(0\)\
\-\ craniopharyngioma\ \(24\)\
\-\ hypothalamic\\ hamartoma\ \(0\)\
\-\ metastasis\ \(206\)\
\-\ optic\\ glioma\ \(7\)\
\-\ eg\\/langerhans\\ cell\\ histiocytosis\ \(0\)\
\-\ 4\\ y\\.o\\.\\ girl\\ presents\\ with\\ precocious\\ puberty\ \(1\)\
\-\ supracellar\\ masses\\ in\\ children\\ can\\ be\\ separated\\ with\\ some\\ degree\\ of\\ certainty\\ based\\ on\\ their\\ imaging\\ characteristics\\.\\ \\ further\\ more\\,\\ clinical\\ signs\\ and\\ symptoms\\ further\\ help\\ in\\ the\\ differentiation\\ process\\.\\ \\ grade\\ ii\\ astrocytoma\\ may\\ be\\ the\\ most\\ difficult\\ to\\ exclude\\ with\\ high\\ signal\\ on\\ pd\\ and\\ no\\ enhancement\\.\\ \\ sarcodoisis\\ and\\ tb\\ were\\ unlikely\\ because\\ of\\ the\\ lack\\ of\\ other\\ intracranial\\ and\\ extracranial\\ findings\\ and\\ the\\ low\\ clinical\\ suspicion\\.\\ \\ an\\ arachnoid\\ cyst\\ was\\ unlikely\\ because\\ this\\ was\\ a\\ solid\\ mass\\ by\\ mr\\ characteristics\\.\\ \\ a\\ germ\\ cell\\ tumor\\ such\\ as\\ an\\ epidermoid\\ was\\ unlikely\\ because\\ those\\ tumors\\ tend\\ to\\ be\\ lobulated\\,\\ irregular\\,\\ and\\ appear\\ similar\\ to\\ csf\\ on\\ imaging\\.\\ \\ dermoid\\ tumors\\ usually\\ appear\\ similar\\ to\\ fat\\ and\\ hence\\ would\\ be\\ hyperintense\\ on\\ t1\\ weighted\\ sequences\\.\\ \\ \ \(0\)\
\-\ an\\ entirely\\ solid\\ craniophayrngioma\\ was\\ unlikely\\ based\\ on\\ the\\ lack\\ of\\ enhancement\\ and\\ the\\ fact\\ that\\ most\\ of\\ those\\ tumors\\ are\\ multilobulated\\.\\ \\ metastasis\\ was\\ unlikely\\ based\\ on\\ clinical\\ presentation\\ and\\ the\\ non\\-aggressive\\ appearance\\ of\\ the\\ tumor\\.\\ \\ a\\ grade\\ i\\ \\(pilocytic\\)\\ astrocytoma\\ of\\ the\\ optic\\ chiasm\\ or\\ hypothalamus\\ was\\ unlikely\\ based\\ on\\ the\\ fact\\ that\\ those\\ tumors\\ are\\ hypointense\\ on\\ t1\\ and\\ hyperintense\\ on\\ t2\\,\\ typically\\ heterogeneous\\ with\\ large\\ cystic\\ and\\ solid\\ components\\,\\ and\\ enhance\\ markedly\\.\\ lastly\\ langerhans\\ cell\\ histiocytosis\\ was\\ unlikely\\ because\\ this\\ process\\ thickens\\ the\\ infundibulum\\ which\\ markedly\\ enhances\\ with\\ contrast\\ administration\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ unlikely\\:\\ 0\\.34300825163278764\ \(0\)\
\-\ tumors\\:\\ 0\\.20339691958619552\ \(0\)\
\-\ on\\:\\ 0\\.1837580609066986\ \(0\)\
\-\ supracellar\\:\\ 0\\.17691296929110004\ \(0\)\
\-\ and\\:\\ 0\\.1714442903175764\ \(0\)\
\-\ solid\\:\\ 0\\.16962078821251997\ \(0\)\
\-\ based\\:\\ 0\\.16026707954101732\ \(0\)\
\-\ because\\:\\ 0\\.15462892139884515\ \(0\)\
\-\ the\\:\\ 0\\.14347862728531222\ \(0\)\
\-\ those\\:\\ 0\\.1419914171473059\ \(0\)\
\-\ was\\:\\ 0\\.13493830422781322\ \(0\)\
\-\ hyperintense\\:\\ 0\\.1319950833064003\ \(0\)\
\-\ cell\\:\\ 0\\.1265648438104463\ \(0\)\
\-\ hypothalamic\\:\\ 0\\.12643902367689333\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.12526744972781415\ \(0\)\
\-\ grade\\:\\ 0\\.11932317312048457\ \(0\)\
\-\ langerhans\\:\\ 0\\.11610634858116851\ \(0\)\
\-\ be\\:\\ 0\\.11219003988243398\ \(0\)\
\-\ histiocytosis\\:\\ 0\\.11095356866593997\ \(0\)\
\-\ hamartoma\\:\\ 0\\.10881358944854676\ \(0\)\
\-\ fact\\:\\ 0\\.10611577569648425\ \(0\)\
\-\ clinical\\:\\ 0\\.10516309628398868\ \(0\)\
\-\ germ\\:\\ 0\\.10330706998433054\ \(0\)\
\-\ characteristics\\:\\ 0\\.10143892136073292\ \(0\)\
\-\ arachnoid\\:\\ 0\\.1010471303776945\ \(0\)\
\-\ tb\\:\\ 0\\.09850610006293546\ \(0\)\
\-\ markedly\\:\\ 0\\.09767365492564087\ \(0\)\
\-\ to\\:\\ 0\\.09679584698346488\ \(0\)\
\-\ optic\\:\\ 0\\.09522720379842359\ \(0\)\
\-\ gray\\:\\ 0\\.0946609447648706\ \(0\)\
\-\ lack\\:\\ 0\\.0946609447648706\ \(0\)\
\-\ sarcodoisis\\:\\ 0\\.08845648464555002\ \(0\)\
\-\ craniophayrngioma\\:\\ 0\\.08845648464555002\ \(0\)\
\-\ thickens\\:\\ 0\\.08845648464555002\ \(0\)\
\-\ ii\\:\\ 0\\.08722089898766805\ \(0\)\
\-\ appear\\:\\ 0\\.08712606753189611\ \(0\)\
\-\ of\\:\\ 0\\.0865950521244896\ \(0\)\
\-\ other\\:\\ 0\\.08617376974578475\ \(0\)\
\-\ similar\\:\\ 0\\.08431311060164862\ \(0\)\
\-\ matter\\:\\ 0\\.08423145576917482\ \(0\)\
\-\ process\\:\\ 0\\.08296967788976398\ \(0\)\
\-\ metastasis\\:\\ 0\\.08107972713451463\ \(0\)\
\-\ extracranial\\:\\ 0\\.07630907224119127\ \(0\)\
\-\ certainty\\:\\ 0\\.07501428548908397\ \(0\)\
\-\ cured\\:\\ 0\\.07285057470631515\ \(0\)\
\-\ precocious\\:\\ 0\\.07285057470631515\ \(0\)\
\-\ further\\:\\ 0\\.07205171923671518\ \(0\)\
\-\ that\\:\\ 0\\.07201045310792284\ \(0\)\
\-\ lastly\\:\\ 0\\.07030656039490821\ \(0\)\
\-\ some\\:\\ 0\\.06960397979527023\ \(0\)\
\-\ multilobulated\\:\\ 0\\.06958797266295824\ \(0\)\
\-\ t1\\:\\ 0\\.0689260973962983\ \(0\)\
\-\ believe\\:\\ 0\\.06891898348943605\ \(0\)\
\-\ infundibulum\\:\\ 0\\.06891898348943605\ \(0\)\
\-\ puberty\\:\\ 0\\.06829318591085093\ \(0\)\
\-\ hypothalamus\\:\\ 0\\.06715110305532576\ \(0\)\
\-\ pd\\:\\ 0\\.06662684040481288\ \(0\)\
\-\ separated\\:\\ 0\\.06520530025260088\ \(0\)\
\-\ with\\:\\ 0\\.06498509448562464\ \(0\)\
\-\ medically\\:\\ 0\\.06436159469397183\ \(0\)\
\-\ cyst\\:\\ 0\\.06381530704075206\ \(0\)\
\-\ enhancement\\:\\ 0\\.06367364830961958\ \(0\)\
\-\ hence\\:\\ 0\\.06358546081667518\ \(0\)\
\-\ an\\:\\ 0\\.0634537676582982\ \(0\)\
\-\ mass\\:\\ 0\\.06338352012091807\ \(0\)\
\-\ refractory\\:\\ 0\\.060703162301956395\ \(0\)\
\-\ t1wi\\:\\ 0\\.060430003477092736\ \(0\)\
\-\ entirely\\:\\ 0\\.060164329405229686\ \(0\)\
\-\ t2wi\\:\\ 0\\.059168943705182935\ \(0\)\
\-\ chiasm\\:\\ 0\\.05870711846957403\ \(0\)\
\-\ imaging\\:\\ 0\\.058137020661846846\ \(0\)\
\-\ tumor\\:\\ 0\\.057863133520905476\ \(0\)\
\-\ or\\:\\ 0\\.05772654199510919\ \(0\)\
\-\ most\\:\\ 0\\.05757244080095779\ \(0\)\
\-\ this\\:\\ 0\\.05701895573628291\ \(0\)\
\-\ tend\\:\\ 0\\.05649841226021363\ \(0\)\
\-\ floor\\:\\ 0\\.05597414960970076\ \(0\)\
\-\ may\\:\\ 0\\.055669834410698664\ \(0\)\
\-\ differentiation\\:\\ 0\\.05370890389885971\ \(0\)\
\-\ craniopharyngioma\\:\\ 0\\.053443229826996654\ \(0\)\
\-\ exclude\\:\\ 0\\.053443229826996654\ \(0\)\
\-\ primarily\\:\\ 0\\.05305788784824213\ \(0\)\
\-\ pilocytic\\:\\ 0\\.05305788784824213\ \(0\)\
\-\ suspicion\\:\\ 0\\.05256682104333453\ \(0\)\
\-\ lobulated\\:\\ 0\\.05102093046557801\ \(0\)\
\-\ diseases\\:\\ 0\\.0508189128037844\ \(0\)\
\-\ help\\:\\ 0\\.0508189128037844\ \(0\)\
\-\ arise\\:\\ 0\\.05062101824060965\ \(0\)\
\-\ rounded\\:\\ 0\\.05033154907206706\ \(0\)\
\-\ components\\:\\ 0\\.050236948350677\ \(0\)\
\-\ isointense\\:\\ 0\\.05005047150684427\ \(0\)\
\-\ enhance\\:\\ 0\\.04951163861011755\ \(0\)\
\-\ granulomatous\\:\\ 0\\.04916836392958242\ \(0\)\
\-\ enhances\\:\\ 0\\.04875568475473696\ \(0\)\
\-\ hypointense\\:\\ 0\\.048675215437884764\ \(0\)\
\-\ degree\\:\\ 0\\.048359854406078435\ \(0\)\
\-\ epidermoid\\:\\ 0\\.04805442767446191\ \(0\)\
\-\ teratoma\\:\\ 0\\.04783150987925572\ \(0\)\
\-\ glioma\\:\\ 0\\.04698780432062668\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.04685405741352509\ \(0\)\
\-\ dermoid\\:\\ 0\\.04672213024876362\ \(0\)\
\-\ their\\:\\ 0\\.0459057618862255\ \(0\)\
\-\ difficult\\:\\ 0\\.0459057618862255\ \(0\)\
\-\ children\\:\\ 0\\.04532145881458863\ \(0\)\
\-\ seizures\\:\\ 0\\.04515281983302189\ \(0\)\
\-\ near\\:\\ 0\\.04504200151790179\ \(0\)\
\-\ intracranial\\:\\ 0\\.04450614711821304\ \(0\)\
\-\ sequences\\:\\ 0\\.04424893052358118\ \(0\)\
\-\ administration\\:\\ 0\\.0440479596605612\ \(0\)\
\-\ csf\\:\\ 0\\.04370598225704062\ \(0\)\
\-\ slightly\\:\\ 0\\.04314641372657739\ \(0\)\
\-\ irregular\\:\\ 0\\.04270357435002612\ \(0\)\
\-\ third\\:\\ 0\\.04211572788458741\ \(0\)\
\-\ are\\:\\ 0\\.04197704031499889\ \(0\)\
\-\ weighted\\:\\ 0\\.041258451299207285\ \(0\)\
\-\ ventricle\\:\\ 0\\.04071457995236417\ \(0\)\
\-\ appears\\:\\ 0\\.040505294913778536\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.040033844566586846\ \(0\)\
\-\ defined\\:\\ 0\\.03945954204812037\ \(0\)\
\-\ would\\:\\ 0\\.03915459562644206\ \(0\)\
\-\ typically\\:\\ 0\\.03882987283960526\ \(0\)\
\-\ girl\\:\\ 0\\.03880088478503851\ \(0\)\
\-\ signs\\:\\ 0\\.03865723034971129\ \(0\)\
\-\ presentation\\:\\ 0\\.03807609658584273\ \(0\)\
\-\ although\\:\\ 0\\.037655586377492216\ \(0\)\
\-\ masses\\:\\ 0\\.037655586377492216\ \(0\)\
\-\ mr\\:\\ 0\\.03578960990915645\ \(0\)\
\-\ such\\:\\ 0\\.03557972082624574\ \(0\)\
\-\ resection\\:\\ 0\\.03545593407662489\ \(0\)\
\-\ medical\\:\\ 0\\.035153209270979174\ \(0\)\
\-\ usually\\:\\ 0\\.03482117189603878\ \(0\)\
\-\ fat\\:\\ 0\\.03440769271318736\ \(0\)\
\-\ appearance\\:\\ 0\\.033345670307021305\ \(0\)\
\-\ cystic\\:\\ 0\\.03331274498835382\ \(0\)\
\-\ t2\\:\\ 0\\.031822720156641914\ \(0\)\
\-\ therapy\\:\\ 0\\.03178053083541815\ \(0\)\
\-\ low\\:\\ 0\\.03173852428438995\ \(0\)\
\-\ high\\:\\ 0\\.03143591400317251\ \(0\)\
\-\ signal\\:\\ 0\\.0313549970076097\ \(0\)\
\-\ more\\:\\ 0\\.030372394657143763\ \(0\)\
\-\ is\\:\\ 0\\.03029532412574506\ \(0\)\
\-\ symptoms\\:\\ 0\\.030263783100574565\ \(0\)\
\-\ can\\:\\ 0\\.0290261674818428\ \(0\)\
\-\ were\\:\\ 0\\.028511916703185678\ \(0\)\
\-\ large\\:\\ 0\\.02771423162501363\ \(0\)\
\-\ in\\:\\ 0\\.027519833721452388\ \(0\)\
\-\ findings\\:\\ 0\\.02729886191485349\ \(0\)\
\-\ contrast\\:\\ 0\\.026875140150236027\ \(0\)\
\-\ well\\:\\ 0\\.026782511163290428\ \(0\)\
\-\ presents\\:\\ 0\\.026608094094355005\ \(0\)\
\-\ which\\:\\ 0\\.025151074586676314\ \(0\)\
\-\ by\\:\\ 0\\.023488830577203593\ \(0\)\
\-\ as\\:\\ 0\\.02222093291127764\ \(0\)\
\-\ from\\:\\ 0\\.021967719292921257\ \(0\)\
\-\ no\\:\\ 0\\.017986945913076712\ \(0\)\
